These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3705420)

  • 1. Resistance and immunity of dogs against Babesia canis in an endemic area.
    Martinod S; Laurent N; Moreau Y
    Vet Parasitol; 1986 Feb; 19(3-4):245-54. PubMed ID: 3705420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity of dogs against Babesia canis, its vector tick Dermacentor reticulatus, and Ixodes ricinus in endemic area.
    Martinod S; Brossard M; Moreau Y
    J Parasitol; 1985 Jun; 71(3):269-73. PubMed ID: 4009345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies against Babesia canis in dogs in an endemic area.
    Bobade PA; Oduye OO; Aghomo HO
    Rev Elev Med Vet Pays Trop; 1989; 42(2):211-7. PubMed ID: 2626574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
    Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
    Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three groups of Babesia canis distinguished and a proposal for nomenclature.
    Uilenberg G; Franssen FF; Perié NM; Spanjer AA
    Vet Q; 1989 Jan; 11(1):33-40. PubMed ID: 2655263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody activity to Babesia canis in dogs in North Carolina.
    Levy MG; Breitschwerdt EB; Moncol DJ
    Am J Vet Res; 1987 Mar; 48(3):339-41. PubMed ID: 3551697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and comparison of merozoite antigens of different Babesia canis isolates by serological and immunological investigations.
    Hauschild S; Shayan P; Schein E
    Parasitol Res; 1995; 81(8):638-42. PubMed ID: 8570577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites.
    Adaszek L; Puchalski A; Dec M; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of antibodies against Babesia gibsoni detected by ELISA with recombinant P50.
    Miyama T; Inokuma H; Itamoto K; Okuda M; Verdida RA; Xuan X
    J Vet Med Sci; 2006 Dec; 68(12):1371-3. PubMed ID: 17213713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of canine babesiosis in Hungary suggesting breed predisposition.
    Hornok S; Edelhofer R; Farkas R
    Parasitol Res; 2006 Nov; 99(6):638-42. PubMed ID: 16715235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological survey of Babesia gibsoni infection in dogs in Japan by enzyme-linked immunosorbent assay using B. gibsoni thrombospondin-related adhesive protein antigen.
    Konishi K; Sakata Y; Miyazaki N; Jia H; Goo YK; Xuan X; Inokuma H
    Vet Parasitol; 2008 Aug; 155(3-4):204-8. PubMed ID: 18565675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiology of canine babesiosis and ehrlichiosis in a hospital population.
    Trapp SM; Dagnone AS; Vidotto O; Freire RL; Amude AM; de Morais HS
    Vet Parasitol; 2006 Sep; 140(3-4):223-30. PubMed ID: 16647817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine babesiosis in Europe: how many diseases?
    Matijatko V; Torti M; Schetters TP
    Trends Parasitol; 2012 Mar; 28(3):99-105. PubMed ID: 22265755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Babesia infections in horses, cattle and dogs in southern Germany].
    Boch J
    Tierarztl Prax Suppl; 1985; 1():3-7. PubMed ID: 3892774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP.
    Goo YK; Jia H; Aboge GO; Terkawi MA; Kuriki K; Nakamura C; Kumagai A; Zhou J; Lee EG; Nishikawa Y; Igarashi I; Fujisaki K; Xuan X
    Exp Parasitol; 2008 Apr; 118(4):555-60. PubMed ID: 18155197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.